{"@context":"https:\/\/schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"A First-In-Human, Phase 1, Open-Label, Multicenter Study of ZW251, a Novel Glypican-3 Targeting Antibody-Drug Conjugate, in Participants with Advanced Solid Tumors, Including Hepatocellular Carcinoma","item":"https:\/\/www.regionalcancercare.org\/trials\/a-first-in-human-phase-1-open-label-multicenter-study-of-zw251-a-novel-glypican-3-targeting-antibody-drug-conjugate-in-participants-with-advanced-solid-tumors-including-hepatocellular-carcinoma\/#breadcrumbitem"}]}